Literature DB >> 8592734

Giant cell arteritis.

E Nordborg1, C Nordborg, B E Malmvall, R Andersson, B A Bengtsson.   

Abstract

Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA. In contrast to corticosteroids, nonsteroidal anti-inflammatory drugs have no proven effect on vascular complications to GCA, and cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592734

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.

Authors:  Chagai Grossman; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Gil Bornstein
Journal:  Clin Rheumatol       Date:  2016-03-01       Impact factor: 2.980

3.  Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

Authors:  M A González-Gay; C Garcia-Porrua; M J Rivas; P Rodriguez-Ledo; J Llorca
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.